Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antituberculosis activity of clarithromycin

J Luna-Herrera1, V M Reddy, D Daneluzzi

  • 1Department of Medicine, University of Illinois at Chicago 60612, USA.

Antimicrobial Agents and Chemotherapy
|December 1, 1995
PubMed
Summary

Clarithromycin (CLA) shows limited in vitro tuberculosis activity but is effective within macrophages, especially combined with rifampin (RIF). In mice, CLA demonstrated protective effects, suggesting potential as a secondary tuberculosis treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A two-centre experience of tonsil biopsies in the investigation of patients with tonsillar asymmetry.

Annals of the Royal College of Surgeons of England·2023
Same author

On-site cytotechnician evaluation of the adequacy of fine needle aspiration in a neck lump clinic.

Annals of the Royal College of Surgeons of England·2013
Same author

Sinusitis: a rare cause for galactorrhoea.

Case reports in otolaryngology·2012
Same author

Inter-observer reliability of operative supervision coding by forty three ENT surgeons of twenty eight operations.

Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery·2012
Same author

p53 immunoprofiling of potentially malignant oral disorders: a case series analysis.

Indian journal of cancer·2012
Same author

Does academic output correlate with better mortality rates in NHS trusts in England?

Public health·2012

Area of Science:

  • Microbiology
  • Pharmacology
  • Infectious Diseases

Background:

  • Tuberculosis remains a significant global health challenge, necessitating novel therapeutic strategies.
  • Macrolide antibiotics, like clarithromycin (CLA), are being explored for their potential antituberculosis activity.
  • Drug resistance in Mycobacterium tuberculosis complicates treatment regimens.

Purpose of the Study:

  • To evaluate the in vitro, intracellular, and in vivo antituberculosis activity of clarithromycin.
  • To assess the synergistic potential of clarithromycin with other antitubercular drugs.
  • To determine the efficacy of clarithromycin as a potential secondary drug for tuberculosis treatment.

Main Methods:

  • In vitro minimum inhibitory concentration (MIC) assays against Mycobacterium tuberculosis strains.

Related Experiment Videos

  • Intracellular activity assessment within J774A.1 macrophages.
  • In vivo efficacy studies in C57BL/6 mice infected with Mycobacterium tuberculosis.
  • Colony-forming unit (CFU) counts in mouse lungs and spleens.

    • Main Results:

    • Clarithromycin exhibited high MICs in vitro but demonstrated significant activity within macrophages, showing synergy with rifampin (RIF).
    • In vivo, clarithromycin protected mice against tuberculosis mortality for 8 weeks.
    • Antitubercular activity of clarithromycin was inferior to isoniazid (INH) and streptomycin but comparable to thiacetazone.

    Conclusions:

    • Clarithromycin possesses intracellular antitubercular activity and can be synergistic with RIF.
    • While less potent than first-line drugs, clarithromycin shows promise as an adjunct therapy for tuberculosis.
    • Further investigation into clarithromycin's role in combination therapy for tuberculosis is warranted.